NDC 63323-463-01 - SENSORCAINE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-463
- Requested NDC
- 63323-463-01
- Package NDCs from labels
- 63323-463-01, 63323-463-57
- Manufacturer
- Sportpharm LLC
- Effective date
- 2026-08-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SENSORCAINE - Sportpharm LLC | Sportpharm LLC | 2026-08-31 | HUMAN PRESCRIPTION DRUG LABEL |
| BUPIVACAINE HCI AND EPINEPHRINE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-30 | HUMAN PRESCRIPTION DRUG LABEL |
| SENSORCAINE MPF - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2023-04-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-463-01 | SENSORCAINE | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 50 | 7 | |
| 63323-463-57 | SENSORCAINE | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-463 | SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ] | 7 | Current NDC, Legacy NDC, 2 package rows | 20230712_bc61a9a6-0a4e-48a9-b908-e5e66b9f23eb.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-463-01 | ML - Milliliter | 63323-463 | 7aa7c5aa-745e-4eda-96be-cf6bae25bae0 | 1 | 2020-03-10 |
| 63323-463-57 | ML - Milliliter | 63323-463 | c0bcd771-c2b9-4f60-ab62-3248a9642b0f | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ARTICAINE | ARTICAINE HYDROCHLORIDE AND EPINEPHRINE | Benco Dental | 4524cb96-40f7-471f-bfc6-1dcab47628ec | 2024-03-01 | Warnings, Adverse reactions | 30Q7KI53AK |
| Citanest Forte DENTAL | PRILOCAINE HCL AND EPINEPHRINE | Novocol Pharmaceutical of Canada, Inc. | 801a4f80-397b-46c5-ad3e-a80594e7bda2 | 2024-02-29 | Warnings, Adverse reactions | 30Q7KI53AK |
| Citanest Forte DENTAL | PRILOCAINE HCL AND EPINEPHRINE | Dentsply Pharmaceutical Inc. | 60c8710b-ae55-4fdf-e053-2991aa0adc75 | 2024-02-29 | Warnings, Adverse reactions | 30Q7KI53AK |
| EPST PLUS | CARDUUS MARIANUS, CISTUS CANADENSIS, DULCAMARA, GALIUM APARINE, MAGNESIA MURIATICA, NATRUM SULPHURICUM, VISCUM ALBUM, MURIATICUM ACIDUM, FOLLICULINUM, AQUA MARINA, AILANTHUS GLANDULOSUS, BARYTA MURIATICA, CADMIUM METALLICUM, CEANOTHUS AMERICANUS, COCCULUS INDICUS, IRIDIUM METALLICUM, THUJA OCCIDENTALIS, CINCHONA OFFICINALIS, CALCAREA CARBONICA, CROTALUS CASCAVELLA | Deseret Biologicals, Inc. | c2bb50a8-e4f9-4af4-aefc-53c9c3cfcc25 | 2024-02-27 | Warnings | 451W47IQ8X QTT17582CB |
| LIDOCAINE HCI AND EPINEPHRINE | LIDOCAINE HCI AND EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | a0997348-6274-060a-e053-2a95a90abea7 | 2024-02-22 | Warnings, Adverse reactions | 30Q7KI53AK |
| LIDOCAINE HCI AND EPINEPHRINE | LIDOCAINE HCI AND EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | a09af094-7cfc-1d47-e053-2a95a90a6b69 | 2024-02-22 | Warnings, Adverse reactions | 30Q7KI53AK |
| Vivacaine | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Septodont, Inc. | b4c60d8e-e350-45b2-9d6b-5815eeb6c994 | 2024-02-16 | Warnings, Adverse reactions | 30Q7KI53AK |
| Bladder Relief | CAUSTICUM, NATRUM MURIATICUM, NUX VOMICA, PULSATILLA (VULGARIS), SEPIA, STAPHYSAGRIA, THUJA OCCIDENTALIS | The Magni Company | b09bf037-703f-4c22-8535-b33d586ebefa | 2024-02-08 | Warnings | 451W47IQ8X |
| Marcaine with Epinephrine | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | Hospira, Inc. | 93cf0914-de08-4ec6-8f8c-d663243b9958 | 2024-02-02 | Boxed warning, Warnings, Adverse reactions | 1012384 1867596 1012377 1867594 30Q7KI53AK 7TQO7W3VT8 |
| Natrum Muriaticum | SODIUM CHLORIDE | SEVENE USA | 11008014-fff6-4d5a-8c5c-a20443d7cc23 | 2024-01-30 | Warnings | 451W47IQ8X |
| BUPIVACAINE HCI AND EPINEPHRINE | BUPIVACAINE HCI AND EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | 99516811-56e2-9c8a-e053-2a95a90ac9cb | 2024-01-30 | Warnings, Adverse reactions | ANDA070968 51662-1399-2 51662-1399-1 51662-1399-3 51662-1399 10328ddf-6e3b-c9e0-e063-6294a90a52ed 99516811-56e2-9c8a-e053-2a95a90ac9cb 30Q7KI53AK 7TQO7W3VT8 |
| SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) | SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) | HF Acquisition Co LLC, DBA HealthFirst | 946ce625-3647-5083-e053-2a95a90a1ebc | 2024-01-30 | Boxed warning, Warnings, Adverse reactions | ANDA070967 1012377 30Q7KI53AK 7TQO7W3VT8 |
| LACTATED RINGERS | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | a14ca7d9-de30-a303-e053-2a95a90a5304 | 2024-01-27 | Warnings, Adverse reactions | 451W47IQ8X |
| 0.9% SODIUM CHLORIDE | 0.9% SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | e5247ed5-6170-c13f-e053-2a95a90a4101 | 2024-01-27 | Warnings, Adverse reactions | 451W47IQ8X |
| BSS | BALANCED SALT SOLUTION | Alcon Laboratories, Inc. | 4bd4d59c-eb3b-4a5e-9eb7-ae95b0a92bea | 2024-01-25 | Warnings, Adverse reactions | 451W47IQ8X |
| CIRCULATION HP | ARNICA MONTANA, AURUM METALLICUM, CACTUS GRANDIFLORUS, CALCAREA CARBONICA, LACHESIS MUTUS, NATRUM MURIATICUM, NUX VOMICA, PHOSPHORUS, SOLIDAGO VIRGAUREA, | Energique, Inc. | 464d208b-3893-4ec6-9868-12ef6807b98d | 2024-01-23 | Warnings | 451W47IQ8X |
| DERMA SCALE HP | ARSENICUM IODATUM, BORAX, GRAPHITES, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, PETROLEUM, SEPIA, SULPHUR | Energique, Inc. | 64961787-7e9a-4e6f-98ce-0f51934155cf | 2024-01-23 | Warnings | 451W47IQ8X |
| XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE) | XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE) | HF Acquisition Co LLC, DBA HealthFirst | 971439ed-4507-7a30-e053-2a95a90a1f1c | 2024-01-22 | Warnings, Adverse reactions | 30Q7KI53AK |
| LIDOCAINE HCI AND EPINEPHRINE WITH EPINEPHRINE | LIDOCAINE HCI AND EPINEPHRINE WITH EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | 94e9f2db-af29-032e-e053-2995a90a7f7b | 2024-01-22 | Warnings, Adverse reactions | 30Q7KI53AK |
| BUPIVACAINE HCI | BUPIVACAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | e37e1599-db88-2fcd-e053-2995a90a00e5 | 2024-01-22 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.